ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatm…
Biotechnology
US, South San Francisco [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared ALX Oncology Holdings Inc. (ALXO) to it's peer group.
Peer Group
RVMD IMTX CRNX AVTE CGEM CABA PASG CCCC BDTX VIRX MLYS EWTX DYN TCRR BMEA BCAB IPSC EYPT STOK BCEL
Compare Together
Loading...